Skip to Content

Theryttrex

Active Substance: yttrium [90Y] chloride
Common Name: yttrium [90Y] chloride
ATC Code: V09
Marketing Authorisation Holder: MDS Nordion S.A.
Active Substance: yttrium [90Y] chloride
Status: Withdrawn
Authorisation Date: 2003-01-07
Therapeutic Area: Radionuclide Imaging
Pharmacotherapeutic Group: Diagnostic radiopharmaceuticals

Therapeutic Indication

To be used only for the radiolabelling of carrier molecules which have been specifically developed and authorised for radiolabelling with this radionuclide.
Radiopharmaceutical precursor - Not intended for direct application to patients.

The marketing authorisation for Theryttrex has been withdrawn at the request of the marketing authorisation holder

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide